LBA
ONCR

Letko, Brosseau & Associates’s Oncorus, Inc. ONCR Stock Holding History

Letko, Brosseau & Associates’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-59,150
Closed -$50K – 103
2022
Q3 		$50K Hold
59,150
– – ﹤0.01% 100
2022
Q2 		$75K Hold
59,150
– – ﹤0.01% 98
2022
Q1 		$105K Buy
59,150
+34,400
+139% +$96.4K ﹤0.01% 100
2021
Q4 		$130K Hold
24,750
– – ﹤0.01% 106
2021
Q3 		$231K Hold
24,750
– – ﹤0.01% 103
2021
Q2 		$342K Buy
24,750
+5,000
+25% +$77.2K ﹤0.01% 97
2021
Q1 		$275K Buy
19,750
+8,750
+80% +$181K ﹤0.01% 100
2020
Q4 		$356K Buy
+11,000
New +$255K ﹤0.01% 100

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return